Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

Finasteride negatively affects fish reproduction and gonadal development.

GPT-4 performs well on medical exams but still needs human doctors for critical thinking.

Apoptosis may contribute to hair loss in androgenetic alopecia.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Exposure to certain chemicals in food and containers may increase the risk of early breast development in young girls.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

An integrative approach combining medical, nutritional, and lifestyle changes effectively manages female pattern hair loss.

Palash basti improved PMOS symptoms in a 26-year-old woman.